Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sirisha Nagapattinam"'
Autor:
Anushikha Thakur, Rekha Nagpal, Avik Kumar Ghosh, Deepak Gadamshetty, Sirisha Nagapattinam, Malini Subbarao, Shreshtha Rakshit, Sneha Padiyar, Suma Sreenivas, Nagaraja Govindappa, Harish V. Pai, Ramakrishnan Melarkode Subbaraman
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-21 (2021)
Abstract Sequence variants (SV) in protein bio therapeutics can be categorized as unwanted impurities and may raise serious concerns in efficacy and safety of the product. Early detection of specific sequence modifications, that can result in altered
Externí odkaz:
https://doaj.org/article/5e77fcb98c3d4da6a2b92852977e8e65
Autor:
Anushikha Thakur, Rekha Nagpal, Avik Kumar Ghosh, Deepak Gadamshetty, Sirisha Nagapattinam, Malini Subbarao, Shreshtha Rakshit, Sneha Padiyar, Suma Sreenivas, Nagaraja Govindappa, Harish V. Pai, Ramakrishnan Melarkode Subbaraman
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/81ea75bf02d5412797c0e4ff82e64134
Autor:
Shreshtha Rakshit, Ramakrishnan Melarkode Subbaraman, Suma Sreenivas, Sneha Padiyar, Anushikha Thakur, Malini Subbarao, Sirisha Nagapattinam, Rekha Nagpal, H. Pai, Deepak Gadamshetty, Nagaraja Govindappa, Avik Kumar Ghosh
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-21 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-21 (2021)
Sequence variants (SV) in protein bio therapeutics can be categorized as unwanted impurities and may raise serious concerns in efficacy and safety of the product. Early detection of specific sequence modifications, that can result in altered physicoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ec3698e6030a64a6339833ab041f4f
http://europepmc.org/articles/PMC8225904
http://europepmc.org/articles/PMC8225904
Autor:
Ramakrishnan Melarkode Subbaraman, Suma Sreenivas, H. Pai, Sneha Padiyar, Nagaraja Govindappa, Avik Kumar Ghosh, Anushikha Thakur, Malini Subbarao, Sirisha Nagapattinam, Rekha Nagpal, Shreshtha Rakshit, Deepak Gadamshetty
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Scientific Reports
Scientific Reports
Sequence variants (SV) in protein bio therapeutics can be categorized as unwanted impurities and may raise serious concerns in efficacy and safety of the product. Early detection of specific sequence modifications, that can result in altered physicoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c6e87f2f3b16286929ec34d8e72172
https://doaj.org/article/81ea75bf02d5412797c0e4ff82e64134
https://doaj.org/article/81ea75bf02d5412797c0e4ff82e64134